|
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer |
|
|
|
Titel: |
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer |
Auteur: |
LaBonte, M.J. Wilson, P.M. Yang, D. Zhang, W. Ladner, R.D. Ning, Y. Gerger, A. Bohanes, P.O. Benhaim, L. El-khoueiry, R. El-khoueiry, A. Lenz, H.-J. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 23 () nr. 6 pagina's 1455-1464 |
Jaar: |
2012 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|